Omair Chaudhary, MD
NPI 1598055014 · Pulmonary Disease Physician · York, PA
Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1598055014
- Entity type
- Individual
- Primary specialty
- Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- Yes
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Student, Health Care
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
15 yrs in NPPES registry
- Profile completeness25% of score
83% of core fields populated
- Practice footprint15% of score
3 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
894 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Critical Care, First 30-74 Minutes99291 | 294 | $202 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 119 | $119 |
| Test to Examine How Well the Lungs Exchange Gases94729 | 86 | $8 |
| Test to Measure Expiratory Airflow and Volume Changes Before and After Medication Administration94060 | 71 | $10 |
| Test to Determine Lung Volumes Using Sensors94726 | 70 | $11 |
| Test to Examine How Well the Lungs Exchange Gases94729 | 44 | $8 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 12 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta | 113 | 28 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 84 | 40 |
| Prednisone | 53 | 43 |
| Azithromycin | 43 | 33 |
| Fluticasone/Vilanterolbrand: Breo Ellipta | 27 | — |
| Fluticasone Propionate | 19 | — |
| Omeprazole |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$90 across 3 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (2)
- 750 E Adams StSyracuse, NY 13210-2342Phone: (315) 464-5136
- 1001 S George St Fl 2York, PA 17403-3676Phone: (717) 851-2465Fax: (717) 741-3043
Registry dates
- Enumerated
- 2011-04-18
- Last updated
- 2018-09-20
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.